The ReBuilder System(R) is an electronic device that restores nerve function, increases blood flow, cancels pain, and reduces numbness and tingling that sells for $399-$699 retail and is available via the Internet.
Twenty million, eight hundred thousand children and adults, or 7% of the U.S. population suffer from diabetes. Thirty percent of those diagnosed with diabetes will eventually suffer from peripheral neuropathy, pain and numbness in the feet and hands that can lead to complete loss of mobility, gangrene, and eventual amputations. $132 Billion per year is the current cost of treating diabetes, or 1 of every 10 health care dollars spent. Neuropathy sufferers constitute 33% of this market, or 43.56 billion dollars in potential market. ReBuilder Medical Technologies, Inc. is a company in its infancy that has targeted 1% of this market, or $43.5 million dollars in its next two market years, and is on course to meet this goal. Its only primary competition is from drug companies whose therapy has proven less successful and prone to side-effects and addiction.
About ReBuilder Medical Technologies, Inc.:
ReBuilder Medical Technologies, Inc is an emerging medical device manufacturer of innovative technologies founded by world renowned medical device inventor David B. Phillips, Ph.D. ReBuilder Medical Technologies's flagship product is its FDA registered ReBuilder System(R) for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) which focus on prescription drugs with powerful side effects, the ReBuilder System(R) is a portable, battery powered medical product that provides a new non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.
ReBuilder Medical also manufactures the Phillips Molluscum Treatment
System(TM) for t
'/>"/>
| SOURCE ReBuilder Medical Technologies, Inc. Copyright©2007 PR Newswire. All rights reserved |